Jump to Navigation

defective drugs Archives

Wave of Actos lawsuits continues to grow

After Actos and Avandia Problems, FDA Learns its Lesson

Actos Bladder Cancer Cases Continue to Increase in Number

Will Financial Disclosure Rules Reduce Medical Malpractice Claims?

Dangerous Drugs: A Tale of Two Recalls

Philadelphia Jury Rules Dangerous Hormone Replacement Drugs Responsible for Cancer

Merck to Pay Millions for Marketing Dangerous Drug

Anti-Smoking Drug Chantix Coming Under Scrutiny as Suicide Risk

Topamax Drug Lawsuits Move Forward